H. Henry Li

2.4k total citations
35 papers, 1.2k citations indexed

About

H. Henry Li is a scholar working on Genetics, Hematology and Nutrition and Dietetics. According to data from OpenAlex, H. Henry Li has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Genetics, 14 papers in Hematology and 8 papers in Nutrition and Dietetics. Recurrent topics in H. Henry Li's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (32 papers), Hemophilia Treatment and Research (14 papers) and Vitamin K Research Studies (8 papers). H. Henry Li is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (32 papers), Hemophilia Treatment and Research (14 papers) and Vitamin K Research Studies (8 papers). H. Henry Li collaborates with scholars based in United States, Germany and United Kingdom. H. Henry Li's co-authors include Robyn J. Levy, Marc A. Riedl, William R. Lumry, Marilyn Campion, William E. Pullman, Patrick T. Horn, Timothy Craig, Donald McNeil, Albert L. Sheffer and Marco Cicardi and has published in prestigious journals such as New England Journal of Medicine, Journal of Allergy and Clinical Immunology and Journal of Adolescent Health.

In The Last Decade

H. Henry Li

33 papers receiving 1.1k citations

Peers

H. Henry Li

GENET

RHEUM

PFM

HEMAT

IMMUN

Inmaculada Martinez‐Saguer Germany

Anthony J. Castaldo United States

Mark Davis‐Lorton United States

D. Garau Italy

Michiaki Koike Japan

Barbara Scappini Italy

Cristina Panuzzo Italy

E. Regazzi Italy

Patrick Philip France

Marek Kiełbiński Poland

Inmaculada Martinez‐Saguer Germany

H. Henry Li

1.1k ×1.0

GENET

506 ×1.1

RHEUM

418 ×1.1

PFM

373 ×1.1

HEMAT

194 ×0.7

IMMUN

Citations per year, relative to H. Henry Li H. Henry Li (= 1×) peers Inmaculada Martinez‐Saguer

Countries citing papers authored by H. Henry Li

Since Specialization

Citations

This map shows the geographic impact of H. Henry Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Henry Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Henry Li more than expected).

Fields of papers citing papers by H. Henry Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Henry Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Henry Li. The network helps show where H. Henry Li may publish in the future.

Co-authorship network of co-authors of H. Henry Li

This figure shows the co-authorship network connecting the top 25 collaborators of H. Henry Li. A scholar is included among the top collaborators of H. Henry Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Henry Li. H. Henry Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kuan, Fa‐Chuan, Chih‐Kai Hong, Wei‐Ren Su, et al.. (2025). Evaluating Barriers to Achieving the Minimal Important Change in Older Patients With Hip Fractures After Post-Acute Care. Geriatric Orthopaedic Surgery & Rehabilitation. 16. 2554111649–2554111649.

Li, H. Henry, Neetu Talreja, Richard F. Lockey, et al.. (2025). Pharmacokinetics and Pharmacodynamics of neffy, Epinephrine Nasal Spray, in Pediatric Allergy Patients. The Journal of Allergy and Clinical Immunology In Practice. 13(6). 1335–1341.e1. 2 indexed citations

Maurer, Marcus, William R. Lumry, H. Henry Li, et al.. (2023). Lanadelumab in Patients 2 to Less Than 12 Years Old With Hereditary Angioedema: Results From the Phase 3 SPRING Study. The Journal of Allergy and Clinical Immunology In Practice. 12(1). 201–211.e6. 15 indexed citations

Lumry, William R., Bruce L. Zuraw, Marco Cicardi, et al.. (2021). Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study. Orphanet Journal of Rare Diseases. 16(1). 329–329. 24 indexed citations

Bork, Konrad, John Anderson, Teresa Caballero, et al.. (2021). Assessment and management of disease burden and quality of life in patients with hereditary angioedema: a consensus report. Allergy Asthma and Clinical Immunology. 17(1). 40–40. 59 indexed citations

Busse, Paula J., Sandra C. Christiansen, Marc A. Riedl, et al.. (2020). US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema. The Journal of Allergy and Clinical Immunology In Practice. 9(1). 132–150.e3. 202 indexed citations

Li, H. Henry, Timothy Craig, Hilary Longhurst, et al.. (2019). Long-term Safety of Subcutaneous C1-Inhibitor in the Prophylactic Treatment of Hereditary Angioedema. Journal of Allergy and Clinical Immunology. 143(2). AB39–AB39. 3 indexed citations

Li, H. Henry, Bruce L. Zuraw, Hilary Longhurst, et al.. (2019). Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled randomized study. Allergy Asthma and Clinical Immunology. 15(1). 49–49. 9 indexed citations

Li, H. Henry. (2019). Pearls and pitfalls in the diagnosis of hereditary angioedema. Allergy and Asthma Proceedings. 40(4). 282–284. 3 indexed citations

10.

Lumry, William R., Timothy Craig, Bruce L. Zuraw, et al.. (2018). Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema. The Journal of Allergy and Clinical Immunology In Practice. 6(5). 1733–1741.e3. 67 indexed citations

11.

Li, H. Henry, et al.. (2018). Update on the Use of C1-Esterase Inhibitor Replacement Therapy in the Acute and Prophylactic Treatment of Hereditary Angioedema. Clinical Reviews in Allergy & Immunology. 56(2). 207–218. 29 indexed citations

12.

Pawaskar, Dipti, Michael A. Tortorici, Bruce L. Zuraw, et al.. (2018). Population pharmacokinetics of subcutaneous C1‐inhibitor for prevention of attacks in patients with hereditary angioedema. Clinical & Experimental Allergy. 48(10). 1325–1332. 8 indexed citations

13.

Farkas, Henriette, Avner Reshef, Werner Aberer, et al.. (2017). Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema. The Journal of Allergy and Clinical Immunology In Practice. 5(6). 1671–1678.e2. 39 indexed citations

14.

Li, H. Henry, Dumitru Moldovan, Jonathan A. Bernstein, et al.. (2015). Recombinant Human-C1 Inhibitor Is Effective and Safe for Repeat Hereditary Angioedema Attacks. The Journal of Allergy and Clinical Immunology In Practice. 3(3). 417–423. 30 indexed citations

15.

Li, H. Henry, Paula J. Busse, William R. Lumry, et al.. (2014). Comparison of Chromogenic and ELISA Functional C1 Inhibitor Tests in Diagnosing Hereditary Angioedema. The Journal of Allergy and Clinical Immunology In Practice. 3(2). 200–205. 33 indexed citations

16.

Li, H. Henry, Marilyn Campion, Timothy Craig, et al.. (2013). Analysis of hereditary angioedema attacks requiring a second dose of ecallantide. Annals of Allergy Asthma & Immunology. 110(3). 168–172. 12 indexed citations

17.

Lumry, William R., H. Henry Li, Robyn J. Levy, et al.. (2011). Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial. Annals of Allergy Asthma & Immunology. 107(6). 529–537.e2. 178 indexed citations

18.

Sheffer, Albert L., Marilyn Campion, Robyn J. Levy, et al.. (2011). Ecallantide (DX-88) for acute hereditary angioedema attacks: Integrated analysis of 2 double-blind, phase 3 studies. Journal of Allergy and Clinical Immunology. 128(1). 153–159.e4. 49 indexed citations

19.

Cicardi, Marco, Robyn J. Levy, Donald McNeil, et al.. (2010). Ecallantide for the Treatment of Acute Attacks in Hereditary Angioedema. New England Journal of Medicine. 363(6). 523–531. 234 indexed citations

20.

Levy, Robyn J., William R. Lumry, Donald McNeil, et al.. (2010). EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema. Annals of Allergy Asthma & Immunology. 104(6). 523–529. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact